Cohick W S, Gockerman A, Clemmons D R
Department of Medicine, University of North Carolina School of Medicine, Chapel Hill 27599-7170, USA.
J Cell Physiol. 1995 Jul;164(1):187-96. doi: 10.1002/jcp.1041640123.
Growth factors such as platelet-derived growth factor (PDGF) and insulin-like growth factor (IGF-I) stimulated proliferation and migration of vascular smooth muscle cells (SMC). IGF-I bioactivity is modulated by high-affinity binding proteins (IGFBP) which are important regulators of these processes. Porcine vascular SMC synthesize IGFBP-2 and IGFBP-4 in vitro. In the present study, levels of IGFBP-2 in conditioned media (CM) were increased approximately 1.6 to 2.2-fold when cells were exposed to PDGF (20 ng/ml) or insulin (5 micrograms/ml) for 24 hr following a 24 hr incubation in serum-free media, or following a 72 hr exposure to either growth factor. Similar increases in IGFBP-2 mRNA levels were observed. Exposure of cells to PDGF for 24 hr without prior serum deprivation resulted in smaller (47 +/- 11%) increases in IGFBP-2 protein levels but failed to alter mRNA levels. IGF-I, FGF, TGF-beta and EGF failed to increase IGFBP-2 using either experimental paradigm. In contrast, IGFBP-2 protein levels were consistently decreased (75 +/- 14%) after 72 hr of exposure to IGF-II without corresponding decreases in IGFBP-2 mRNA levels. Immunoprecipitation of [35S]methionine-labeled IGFBP-2 indicated that this decrease was not due to a decrease in synthesis of IGFBP-2. Immunoblot analysis of CM from cells treated with IGF-II indicated that the decrease in intact protein corresponded with an increase in two non-IGF binding IGFBP-2 fragments of 22 and 14 kD. Increased abundance of these fragments was also observed following IGF-I exposure, although corresponding decreases in intact IGFBP-2 were not usually observed. The relative abundance of these fragments did not appear to be affected by treatment with PDGF or insulin. In contrast to IGFBP-2, regulation of the levels of IGFBP-4 in CM did not appear to be altered by serum deprivation. Insulin consistently increased IGFBP-4 mRNA and protein levels under all situations. PDGF tended to increase IGFBP-4 protein levels, although this effect was less consistent and not as great as the increase observed with insulin. Treatment with IGF-I or -II consistently decreased IGFBP-4 levels in CM but tended to increase their mRNA levels under all situations. These data indicate that insulin, PDGF, and the IGFs regulate both IGFBP-2 and IGFBP-4. While PDGF and insulin stimulate IGFBP-2 and 4 synthesis, the IGFs appear to activate protease(s) which regulate IGFBP-2 and -4 levels post-translationally.(ABSTRACT TRUNCATED AT 400 WORDS)
血小板衍生生长因子(PDGF)和胰岛素样生长因子(IGF-I)等生长因子可刺激血管平滑肌细胞(SMC)的增殖和迁移。IGF-I的生物活性受高亲和力结合蛋白(IGFBP)调节,而IGFBP是这些过程的重要调节因子。猪血管SMC在体外可合成IGFBP-2和IGFBP-4。在本研究中,当细胞在无血清培养基中孵育24小时后,再暴露于PDGF(20 ng/ml)或胰岛素(5微克/毫升)24小时,或暴露于任何一种生长因子72小时后,条件培养基(CM)中IGFBP-2的水平增加了约1.6至2.2倍。IGFBP-2 mRNA水平也有类似增加。在未预先剥夺血清的情况下,细胞暴露于PDGF 24小时导致IGFBP-2蛋白水平增加幅度较小(47±11%),但未能改变mRNA水平。使用任何一种实验模式,IGF-I、FGF、TGF-β和EGF均未能增加IGFBP-2。相反,暴露于IGF-II 72小时后,IGFBP-2蛋白水平持续下降(75±14%),而IGFBP-2 mRNA水平没有相应下降。对[35S]甲硫氨酸标记的IGFBP-2进行免疫沉淀表明,这种下降并非由于IGFBP-2合成减少。对用IGF-II处理的细胞的CM进行免疫印迹分析表明,完整蛋白的减少与两个22 kD和14 kD的非IGF结合IGFBP-2片段的增加相对应。在暴露于IGF-I后也观察到这些片段丰度增加,尽管通常未观察到完整IGFBP-2相应减少。这些片段的相对丰度似乎不受PDGF或胰岛素处理的影响。与IGFBP-2相反,血清剥夺似乎未改变CM中IGFBP-4的水平调节。在所有情况下,胰岛素均持续增加IGFBP-4 mRNA和蛋白水平。PDGF倾向于增加IGFBP-4蛋白水平,尽管这种效应不太一致,且不如胰岛素引起的增加幅度大。用IGF-I或-II处理在所有情况下均持续降低CM中IGFBP-4水平,但倾向于增加其mRNA水平。这些数据表明,胰岛素、PDGF和IGF可调节IGFBP-2和IGFBP-4。虽然PDGF和胰岛素刺激IGFBP-2和4的合成,但IGF似乎激活了蛋白酶,这些蛋白酶在翻译后调节IGFBP-2和-4的水平。(摘要截断于400字)